Clinical Trials in Hanover, Maryland
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC641 enrolled193 locationsNCT06319820
Recruiting
Phase 3
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Ferring Pharmaceuticals250 enrolled73 locationsNCT06545955
Recruiting
Phase 1Phase 2
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Non-muscle Invasive Bladder Cancer With Carcinoma in SituSuperficial Bladder Cancer
enGene, Inc.350 enrolled101 locationsNCT04752722
Recruiting
Phase 4
Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
Urethral Stricture
Urotronic Inc.34 enrolled9 locationsNCT05383274
Recruiting
Not Applicable
Ambulatory Long Length URodynamics Evaluation
Benign Prostatic HyperplasiaUrodynamicsUrinary Bladder, Overactive+4 more
Bright Uro101 enrolled7 locationsNCT07425015
Recruiting
Phase 2
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-risk Non-muscle Invasive Bladder Cancer
CG Oncology, Inc.325 enrolled65 locationsNCT06567743
Recruiting
Not Applicable
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
Pacific Edge Limited1,000 enrolled15 locationsNCT06394869
Recruiting
NXT Post-Market Clinical Follow-up
Urinary IncontinenceUrinary Bladder, NeurogenicUrinary Bladder, Overactive+2 more
Laborie Medical Technologies Inc.180 enrolled4 locationsNCT06336304